EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Hepatocellular Carcinoma Progression is Regulated by KIF4A via the HSP90-CDC37 Complex/AKT Pathway

Haonan Zhou, Di Wu, Ruilin Xing, Shiqi Liu, Haomin Wu, Yubo Wu, Yifan Jin, Hongwei Yang, Chengshuo Zhang, Guang Wang, Gang Wu

Journal of Hepatocellular Carcinoma · 2026-11 · Volume 13 · 1-24

DOI: 10.2147/jhc.s641288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-11. Verfasst von Haonan Zhou und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatocellular carcinoma (HCC) seriously endangers the life and health of people all over the world, so it is necessary to further study the pathogenesis of hepatocellular carcinoma. Kinesin family member 4A (KIF4A) appears to play oncogenic roles in numerous malignancies; however, its involvement in HCC remains unclear.

Methods

This study aimed to elucidate the molecular mechanisms underlying the biological function of KIF4A in HCC progression. Transcriptome sequencing of more than 50 HCC patient tissue samples revealed that KIF4A expression was significantly upregulated in HCC tissues and increased with clinical progression. Functional assays (CCK-8, colony formation, wound-healing, Transwell) were performed following KIF4A knockdown or overexpression in SK-Hep1 and BEL-7402 cells. Downstream molecules were identified using the 4D-DIA quantitative proteomics technique and bioinformatics analysis. Additionally, in vivo experiments using subcutaneous xenograft tumor and xenograft mouse metastatic models established in immunodeficient mice confirmed that KIF4A facilitates HCC growth and metastasis.

Results

Our study provides new insights into the clinical relevance and biological function of KIF4A in HCC. We found that KIF4A was significantly elevated in liver cancer tissues and may be indicative of poor prognosis in patients. Mechanistically, our results suggest that KIF4A promotes the proliferation and metastasis of HCC cells by inhibiting the degradation of HSP90 proteasome pathway, increasing the expression of the latter in HCC, and regulating AKT phosphorylation via the HSP90-CDC37 complex. These findings provide a novel theoretical foundation for understanding the molecular mechanisms of HCC progression, as well as presents novel targets developing treatments of HCC.

Discussion

Our findings revealed up-regulated KIF4A expression in HCC cell lines and tissues, and may be indicative of poor prognosis in HCC patients. KIF4A mediates HCC progression by regulating the HSP90-CDC37 complex /AKT pathway. A) Compartmented pathway schematic labeled Extracellular matrix, Cytoplasm and Nuclear. In the Nuclear area, a DNA icon labeled KIF4A connects by a dashed arrow to a rounded rectangle labeled KIF4A with a downward arrow symbol. From that rectangle, a dashed arrow goes to a proteasome icon labeled Proteasome. A solid arrow from the proteasome points to shapes labeled Protein degradation. Below the proteasome are two protein shapes labeled HSP90 and CDC37; a dashed arrow rises from HSP90 toward the proteasome, with a small label MG132 beside the dashed arrow. On the right, an oval labeled Akt connects by a dashed arrow to a second Akt oval that has a P in a circle above it and a downward arrow symbol beside it. Between the two Akt ovals, ATP and ADP are shown with curved arrows indicating ATP to ADP during the phosphorylation step. B) Same compartment labels and overall layout. Differences from A): the DNA icon labeled KIF4A connects by a solid arrow to a rounded rectangle labeled KIF4A with an upward arrow symbol. A solid arrow from that rectangle points toward the proteasome and a dashed arrow points upward into the proteasome from below. A solid arrow from CDC37 points to an Akt oval. The Akt oval connects by a curved arrow to a second Akt oval with a P in a circle above it and an upward arrow symbol beside it, with ATP and ADP shown around the step. A vertical solid arrow rises from the phosphorylated Akt toward the text Tumor progression.Two schematics show KIF4A, HSP90 CDC37, proteasome and Akt phosphorylation linked to tumor progression.

Zitieren

APA

Zhou, H., Wu, D., Xing, R., Liu, S., Wu, H., Wu, Y., Jin, Y., Yang, H., Zhang, C., Wang, G., & Wu, G. (2026). Hepatocellular Carcinoma Progression is Regulated by KIF4A via the HSP90-CDC37 Complex/AKT Pathway. Journal of Hepatocellular Carcinoma, Volume 13, 1-24. https://doi.org/10.2147/jhc.s641288

Vancouver

Zhou H, Wu D, Xing R, Liu S, Wu H, Wu Y, et al. Hepatocellular Carcinoma Progression is Regulated by KIF4A via the HSP90-CDC37 Complex/AKT Pathway. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-24. doi:10.2147/jhc.s641288

BibTeX
@article{Zhou2026,
  author = {Zhou, Haonan and Wu, Di and Xing, Ruilin and Liu, Shiqi and Wu, Haomin and Wu, Yubo and Jin, Yifan and Yang, Hongwei and Zhang, Chengshuo and Wang, Guang and Wu, Gang},
  title = {Hepatocellular Carcinoma Progression is Regulated by KIF4A via the HSP90-CDC37 Complex/AKT Pathway},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--24},
  doi = {10.2147/jhc.s641288}
}
Kostenlos starten →